Boehringer Allies With Quallent For Push On Adalimumab

Follows Confirmation Of Teva-Alvotech Involvement In Deal With Cigna’s Evernorth

 
• By David Wallace
Handshake
Boehringer has announced an adalimumab deal with Quallent

More from Biosimilars

More from Products